PM Modi responds to US President Trump's praise for India's big HCQ decision amid Covid

Responding to US President Donald Trump, Prime Minister Narendra Modi has taken to Twitter to state that US & India will win the fight against COVID-19 together

President Donald Trump has thanked Prime Minister Narendra Modi for allowing the export of the anti-malarial drug hydroxychloroquine to the US, deemed as a possible cure for the deadly coronavirus, sayingIndia's help in the extraordinary times "will not be forgotten".

President Trump and Prime Minister Modi spoke over the phone last week. During the call, Trump requested Modi to lift the hold on the American order of hydroxychloroquine, of which India is the major producer

India agreed to lift the ban on the export of hydroxychloroquine to the US. Three Gujarat-based companies would export these tablets to the US, Gujarat Chief Minister Vijay Rupani said on Tuesday.

"I want to thank Prime Minister Modi of India for allowing us to have what we requested for the problem that arose and he was terrific. We will remember it," Trump told reporters at his daily White House news conference on coronavirus on Wednesday.

In a tweet hours earlier, Trump praised Modi for his strong leadership and said that India's help during this crisis will not be forgotten.

"Extraordinary times require even closer cooperation between friends. Thank you India and the Indian people for the decision on HCQ. Will not be forgotten!" he said.

"Thank you, Prime Minister for your strong leadership in helping not just India, but humanity, in this fight!" Trump said in his tweet that went viral and was retweeted more than 60,000 times and liked by over two lakh people.

READ | Audible Clip Of PM Modi's COVID Videoconference With Oppn MPs Leaked; Allegedly From TMC

By Wednesday night, more than 14,600 Americans lost their lives due to the coronavirus and over 4.3 lakhs have tested positive for the dreaded disease.

Scientists and the medical fraternity are racing against time to find a vaccine and a therapeutic solution to the infection that originated in the central Chinese city of Wuhan in December.

Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19 and it is being tested on more than 1,500 coronavirus patients in New York.

Anticipating that it will work, given initial positive results, Trump has bought more than 29 million doses of hydroxychloroquine for potential treatment of COVID-19 patients.

India manufactures 70 per cent of the world's supply of hydroxychloroquine, according to Indian Pharmaceutical Alliance (IPA) secretary-general Sudarshan Jain.

Post a Comment


Top Post Ad

Below Post Ad